Cell Genesys reports further promising results from phase I trial of GVAX pancreatic cancer vaccine Jan. 3, 2001
Pierre Fabre describes bacterial cell wall protein with potential as cancer immunotherapy Dec. 21, 2000
IL-2 variant with T-cell selectivity displays antitumor activity and good tolerance in animals Dec. 12, 2000